Alerts will be sent to your verified email
Verify EmailDANUBE
Danube Industries
|
Dipna Pharma.
|
Mono Pharmacare
|
|
---|---|---|---|
Operational Metrics
|
|||
Financials
|
|||
5 yr Average ROE
|
5.35 % | 17.75 % | 6.96 % |
5yr average Equity Multiplier
|
3.98 | 20.92 | 3.78 |
5yr Average Asset Turnover Ratio
|
1.41 | 1.49 | 0.97 |
5yr Avg Net Profit Margin
|
1.18 % | 0.69 % | 2.29 % |
Price to Book
|
2.62 | 0.0 | 0.0 |
P/E
|
163.25 | 40.21 | 17.62 |
5yr Avg Cash Conversion Cycle
|
73.78 Days | 0.52 Days | 164.46 Days |
Inventory Days
|
20.4 Days | 54.14 Days | 276.94 Days |
Days Receivable
|
88.58 Days | 66.04 Days | 79.75 Days |
Days Payable
|
143.66 Days | 111.59 Days | 65.03 Days |
5yr Average Interest Coverage Ratio
|
120.44 | 1.93 | 2.12 |
5yr Avg ROCE
|
8.45 % | 12.98 % | 9.76 % |
5yr Avg Operating Profit Margin
|
1.4 % | 2.08 % | 5.42 % |
5 yr average Debt to Equity
|
0.41 | 9.25 | 2.25 |
5yr CAGR Net Profit
|
149.66 % | 78.59 % | 28.37 % |
5yr Average Return on Assets
|
1.76 % | 1.13 % | 2.06 % |
Shareholdings
|
|||
Promoter Holding
|
39.93 % | 9.98 % | 56.72 % |
Share Pledged by Promoters
|
0.0 | 0.0 | 0.0 |
Change in Promoter Holding (3 Yrs)
|
8.45 % | -56.58 % | 0.0 |
Change in Mutual Fund Holding (3 Yrs)
|
0.0 | 0.0 | 0.0 |
Danube Industries
|
Dipna Pharma.
|
Mono Pharmacare
|
|
---|---|---|---|
Product Wise Break-Up
|
Product Wise Break-Up
|
-
|
Product Wise Break-Up
|